glp 1 arthritis pain The potential role of GLP‐1 receptor agonists in osteoarthritis - Ryan - 2025 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Osteoarthritis treatment via the GLP-1–mediated

During the initial period of using any new transdermal medication, patients may experience local skin reactions such as mild redness, itching, or irritation at the application site

As there was clear evidence of clinically significant weight loss from the Phase III trials, tirzepatide has been planned to be evaluated as an anti-obesity drug in non-diabetic (SURMOUNT 1 trial), and diabetic (SURMOUNT 2 trial) populations, and on those who are already on intensive lifestyle programmes (SURMOUNT 3 trial)

All labs WNL

A key factor sustaining the compounded GLP-1 market post-shortage is the widespread use of additives

Looking Ahead The increasing popularity of GLP-1 agonists outside traditional diabetic populations means emergency physicians will continue to see complications from these agents